Inventor · disambiguated record
Gordon Raphael Loewen
Also filed as: LOEWEN GORDON · LOEWEN GORDON RAPHAEL
3 granted patents·6 pending applications·8 citations·filing 2019–2022
58Inventor score
Top patents by PatentIndex Score
9 records- 0189US10940141B1Methods for the administration of certain VMAT2 inhibitorsNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Mar 9, 2021·7 cites·30 claims
- 0279US12383536B2CRF receptor antagonists and methods of useNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Aug 12, 2025·1 cites·4 claims
- 0366US2022023266A1Crf1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasiaNEUROCRINE BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 0452US12097193B2Methods for the administration of COMT inhibitorsBIAL—PORTELA & CA S A·Filed 2019·Granted Sep 24, 2024·0 cites·11 claims
- 0551US2024024330A1Crf receptor antagonists and methods of useNEUROCRINE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 0648US2021220345A1Methods for the administration of comt inhibitorsNEUROCRINE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 0748US2024207247A1Methods for the combined administration of deutetrabenazine and a cyp2d6 inhibitorNEUROCRINE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0848US2024197714A1Methods for the administration of certain vmat2 inhibitorsNEUROCRINE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0947US2023255942A1Crf1 receptor antagonist for the treatment of congenital adrenal hyperplasiaNEUROCRINE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gordon Raphael Loewen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →